We found that FOXM1 was associated with overall survival of patients with ccRCC (log-rank P = 1.23e-05, hazard ratio [HR] = 2.007, 95% CI = 1.46–2.742, Figure 6A). Here, FOXM1 is linked to nonpapillary renal cell carcinoma.